Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 17,157 | 10,287 | 63,175 | 75,000 | 8,000 |
| Gross Profit | 17,157 | 10,287 | 63,175 | 75,000 | 8,000 |
| Operating Expenses | 181,568 | 125,441 | 119,989 | 98,879 | 115,432 |
| Operating Income | -164,411 | -115,154 | -56,814 | -23,879 | -107,432 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,041 |
| Other Income | 788 | -13,546 | -982 | 3,948 | 10,985 |
| Pre-tax Income | -163,623 | -128,700 | -57,796 | -19,931 | -97,488 |
| Income Tax | -4 | 24 | N/A | N/A | -152 |
| Net Income Continuous | -163,619 | -128,724 | -57,796 | -19,931 | -97,336 |
| Net Income | $-163,619 | $-128,724 | $-57,796 | $-19,931 | $-97,336 |
| EPS Basic Total Ops | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 |
| EPS Basic Continuous Ops | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 |
| EPS Diluted Total Ops | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 |
| EPS Diluted Continuous Ops | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 |
| EPS Diluted Before Non-Recurring Items | -6.08 | -4.57 | -2.06 | -0.73 | -3.60 |
| EBITDA(a) | $-172,556 | $-115,326 | $-54,231 | $-21,801 | $-108,658 |